AtriCure's Salvatore Privitera sells 8,404 shares

AtriCure, Inc. Chief Technical Officer Salvatore Privitera sold 8,404 shares of common stock at $65 per share on November 4, 2026.

Available on EDGAR 11/05/2026 - 04:18 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:17 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AtriCure, Inc. Chief Technical Officer Salvatore Privitera sold 8,404 shares of common stock at $65 per share on November 4, 2026. The sale was made under a Rule 10b5-1 trading plan adopted on February 20, 2026. After the transaction, he held 134,341 shares directly.

Insider Trade Summary 10b5-1

Net Seller: 8,404 shares

Net Sell 1 txn

Insider Privitera Salvatore

Role Chief Technical Officer

Sold 8,404 shs ($546K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	8,404	$65.00	$546K

Holdings After Transaction: Common Stock — 134,341 shares (Direct)

Footnotes (1)

1. F1. These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026.

Key Figures

Shares sold: 8,404 shares Sale price: $65 per share Shares held after transaction: 134,341 shares

3 metrics

Shares sold 8,404 shares November 4, 2026

Sale price $65 per share November 4, 2026

Shares held after transaction 134,341 shares Held directly after the November 4, 2026 sale

Key Terms

10b5-1 trading plan

1 terms

10b5-1 trading plan regulatory

"sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026"

A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ATRC shares did Salvatore Privitera sell?

Salvatore Privitera, AtriCure’s Chief Technical Officer, sold 8,404 shares of common stock at $65 per share on November 4, 2026, under a Rule 10b5-1 trading plan adopted on February 20, 2026; he held 134,341 shares directly afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Privitera Salvatore

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OHIO 45040-9695

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2026		S		8,404(1)	D	$65	134,341	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026.

Remarks:

	/s/ Salvatore Privitera	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)